Assay Dynamics will utilize process tools through WTC’s Microfabrication Laboratory Access Program to produce and test a novel analytical test card designed for medical diagnostics.
SEATTLE – January 4, 2011 – Washington Technology Center has announced an award under its Microfabrication Laboratory Access Program to Assay Dynamics, LLC for the development of a small medical diagnostic device approximately the size of a credit card.
Assay Dynamics, a Seattle-based biotechnology startup, will receive three months of access to WTC’s Microfabrication Laboratory for a project to produce and test its devices. Once developed, Assay Dynamics’ low-cost test cards will allow health providers to routinely conduct sophisticated diagnostic tests in their offices within minutes, much like blood glucose and cholesterol measurements are being done today.
“The Washington Technology Center’s Microfabrication Laboratory has all the tools required to complete development of the assay card,” said Kjell Nelson, president and founder of Assay Dynamics. “Three months of access will enable us to conduct a comprehensive series of proof-of-principle experiments. Fully proven, our analytical technology will have wide utility in medical diagnostic testing as well as other commercial applications in process control, environmental monitoring, and pharmaceutical R&D.”
The three-month award to Assay Dynamics is made possible through Washington Technology Center’s Microfabrication Laboratory Access Program, a technology stimulus program that provides access to expensive process tools to help small companies accelerate their product development, growth, and ultimately, job creation in Washington.
“As Washington’s economy begins to grow again, innovative startup companies such as Assay Dynamics will help to drive job growth,” state Sen. Jeanne Kohl-Welles (D-Seattle) said. “It’s critical that these promising startups in our state receive the support needed to fully develop, and I’m pleased to see that the Washington Technology Center is helping Assay Dynamics along its path to success.”
“This support will help Assay Dynamics develop a technology with tremendous medical and economic potential,” said state Rep. Mary Lou Dickerson (D-Seattle), who represents the Seattle community where Assay Dynamics is located.
“It is exciting to see promising medical technologies being grown in our state with help from Washington Technology Center,” state Rep. Reuven Carlyle (D-Seattle) said. “The startup of Assay Dynamics is another example of Seattle serving as fertile ground for the commercialization of life sciences R&D.”
More information about the lab access program is available online at www.watechcenter.org/accessprogram.
About Washington Technology Center
The mission of Washington Technology Center is to assist companies in the creation of innovative products and technologies that provide job opportunities for the citizens of Washington state. Through the Investing in Innovation program, Washington Technology Center provides companies with access to critical resources and support such as state and federal funding. Our 15,000-square-foot Microfabrication Laboratory provides companies and university researchers access to state-of-the-art process tools for micro-electromechanical systems (MEMS) research and product/process development. The impact of Washington Technology Center’s work has generated more than $675 million in additional investment for Washington companies and researchers. Learn more at http://www.watechcenter.org/ or call 206-685-1920.